Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

COPD

Showing results (851-860 of 1,319) with videos related to

Pageof 132
Sort By:
COPD|December 7, 2006
Cost-effectiveness of population screening for alpha-1 antitrypsin deficiency: a decision analysisKenneth M Shermock, Thomas R Gildea, Mendel Singer, et al.
COPD|August 31, 2007
The relationship between exercise tolerance and other outcomes in COPDMichael J Berry
COPD|August 31, 2007
Dyspnea and activity limitation in COPD: mechanical factorsDenis E O'Donnell, Pierantonio Laveneziana
COPD|August 31, 2007
Subjective measurement of activity in chronic obstructive pulmonary diseaseNancy Kline Leidy
COPD|August 31, 2007
The impact of change in exercise tolerance on activities of daily living and quality of life in COPD: a patient's perspectiveMary Ann Cruse
COPD|August 31, 2007
The impact of exercise on activities of daily living and quality of life: a primary care physician's perspectiveMark H Belfer
COPD|August 2, 2008
A double-blind crossover study comparing the safety and efficacy of three weeks of Flu/Sal 250/50 bid plus albuterol 180 ug prn q4 hours to Flu/Sal 250/50 bid plus albuterol/Ipratropium bromide 2 puffs prn q4 hours in patients with chronic obstructive pulmonary diseaseRon Balkissoon, Barry Make
COPD|April 9, 2009
The Prevalence of chronic obstructive pulmonary disease among Danes aged 45-84 years: population-based studyJens G Hansen, Lars Pedersen, Kim Overvad, et al.
COPD|April 9, 2009
Venous admixture in COPD: pathophysiology and therapeutic approachesChristopher B Cooper, Bartolome Celli
COPD|April 9, 2009
Obstructive lung disease models: what is valid?Jill M Ferdinands, David M Mannino
Pageof 132

Showing results (851-860 of 1,319) with videos related to

Sort By:
Pageof 132
COPD|December 7, 2006
Cost-effectiveness of population screening for alpha-1 antitrypsin deficiency: a decision analysisKenneth M Shermock, Thomas R Gildea, Mendel Singer, et al.
COPD|August 31, 2007
The relationship between exercise tolerance and other outcomes in COPDMichael J Berry
COPD|August 31, 2007
Dyspnea and activity limitation in COPD: mechanical factorsDenis E O'Donnell, Pierantonio Laveneziana
COPD|August 31, 2007
Subjective measurement of activity in chronic obstructive pulmonary diseaseNancy Kline Leidy
COPD|August 31, 2007
The impact of change in exercise tolerance on activities of daily living and quality of life in COPD: a patient's perspectiveMary Ann Cruse
COPD|August 31, 2007
The impact of exercise on activities of daily living and quality of life: a primary care physician's perspectiveMark H Belfer
COPD|August 2, 2008
A double-blind crossover study comparing the safety and efficacy of three weeks of Flu/Sal 250/50 bid plus albuterol 180 ug prn q4 hours to Flu/Sal 250/50 bid plus albuterol/Ipratropium bromide 2 puffs prn q4 hours in patients with chronic obstructive pulmonary diseaseRon Balkissoon, Barry Make
COPD|April 9, 2009
The Prevalence of chronic obstructive pulmonary disease among Danes aged 45-84 years: population-based studyJens G Hansen, Lars Pedersen, Kim Overvad, et al.
COPD|April 9, 2009
Venous admixture in COPD: pathophysiology and therapeutic approachesChristopher B Cooper, Bartolome Celli
COPD|April 9, 2009
Obstructive lung disease models: what is valid?Jill M Ferdinands, David M Mannino
Pageof 132